DepoDur
DepoDur CII, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of Pacira Pharmaceuticals (formerly SkyePharma PLC). It was approved by the U.S. Food and Drug Administration (FDA) in 2004 for use as a post-surgical pain reliever. In Europe, it was approved by the Medicines and Healthcare products Regulatory Agency in 2006. It is a one-time injection (during or shortly after surgery) that maintains a therapeutically effective level of morphine in the patient's bloodstream for 48 hours.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
DepoDur
DepoDur CII, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of Pacira Pharmaceuticals (formerly SkyePharma PLC). It was approved by the U.S. Food and Drug Administration (FDA) in 2004 for use as a post-surgical pain reliever. In Europe, it was approved by the Medicines and Healthcare products Regulatory Agency in 2006. It is a one-time injection (during or shortly after surgery) that maintains a therapeutically effective level of morphine in the patient's bloodstream for 48 hours.
has abstract
DepoDur CII, previously known ...... nt's bloodstream for 48 hours.
@en
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
960,978,964
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
hypernym
comment
DepoDur CII, previously known ...... nt's bloodstream for 48 hours.
@en
label
DepoDur
@en